首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Cancer immunology immunotherapy

缩写:CANCER IMMUNOL IMMUN

ISSN:0340-7004

e-ISSN:1432-0851

IF/分区:5.8/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引3892条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Kwanpirom Suwanchiwasiri,Chalermchai Somboonpatarakun,Nan Chaiyariti et al. Kwanpirom Suwanchiwasiri et al.
Nasopharyngeal carcinoma (NPC) remains a highly aggressive malignancy with poor outcomes in advanced and recurrent disease. Although immune checkpoint inhibitors combined with chemotherapy improve survival, many patients still experience re...
Hyun-Hee Koh,Seungeun Lee,Chiyoon Oum et al. Hyun-Hee Koh et al.
Purpose: The prognostic significance of tumor-infiltrating lymphocytes (TILs) in colorectal cancer (CRC) is well established; however, existing approaches inadequately capture their spatial distribution. We investigated t...
Yuanmei Zhai,Yehua Yu,Renjun Bao et al. Yuanmei Zhai et al.
Venetoclax plus hypomethylating agents (HMAs) is a standard therapy for older or unfit patients with acute myeloid leukemia (AML); however, some patients exhibit suboptimal responses, potentially associated with T-cell exhaustion. Our precl...
Veera Nurmela,Anna-Mari Schroderus,Satu Tiainen et al. Veera Nurmela et al.
Immune checkpoint inhibitors (ICI) have transformed the treatment of metastatic malignancies, yet only 20-40% of unselected patients benefit. Peripheral blood could offer a minimally invasive and dynamic source for predictive biomarkers of ...
Chunzhao Li,Peng Zhang,Xiaobin Zhao et al. Chunzhao Li et al.
Locoregional CAR-T delivery is increasingly explored for glioblastoma to improve intracranial tumor exposure; however, organ-level biodistribution kinetics after intracranial administration remain poorly quantified in vivo, limiting route-i...
Zhenggang Ren,Yao Huang,Yabing Guo et al. Zhenggang Ren et al.
Background: Patients with hepatocellular carcinoma (HCC) have an unmet need for new therapies that improve survival. This phase II trial investigated the efficacy and safety of ociperlimab and tislelizumab plus BAT1706 (a...
Angelo Gámez-Pozo,Lucía Trilla-Fuertes,Fernando Becerril-Gómez et al. Angelo Gámez-Pozo et al.
Background: Immunotherapy based on anti-PD1 inhibitors has significantly improved survival in advanced melanoma. However, a significant proportion of patients do not benefit, and predicting response to immunotherapy remai...
Atsushi Kamigaichi,Hiroshi Kagamu,Yoshihiro Miyata et al. Atsushi Kamigaichi et al.
Introduction: Tumor-draining lymph nodes (LNs) are critical for initiating and maintaining antitumor immunity. However, systematic LN dissection (LND) remains the standard surgical procedure for lung cancer. This study ai...
Jinyan Feng,Jianchao Liu,Houzhi Yang et al. Jinyan Feng et al.
Background: The role of extrachromosomal DNA (ecDNA)-related genes in osteosarcoma remains largely unexplored. The aim of this study is to investigate the association between ecDNA-related genes and prognosis and tumor mi...